Home Casteddu.com	FAQ My Amedeo About	Flying Publisher
	The Medical Article of the Year 2008: Wellcome Trust Case Control Consortium. Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature 2007; 447:661-78. Free full-text

Prostate Cancer

Free Subscription Articles published in Cancer Retrieve available abstracts of 119 articles: HTML format

Single Articles

June 2008
1. ALBERTSEN P
   Should patients consider active surveillance?
   Cancer. 2008;112:2631-4.
   PubMed     Related articles   
   
   
   
2. CHUN FK , Haese A, Ahyai SA, Walz J, et al
   Critical assessment of tools to predict clinically insignificant prostate cancer at radical prostatectomy in contemporary men.
   Cancer. 2008;.
   PubMed     Related articles    Abstract available
   
   
   
3. CAI T , Bartoletti R
   Is there an optimal comorbidity index for prostate cancer?
   Cancer. 2008;.
   PubMed     Related articles   
   
   
   
4. ALIBHAI SM , Fleshner NE, Naglie G
   Reply to Is There an Optimal Comorbidity Index for Prostate Cancer?
   Cancer. 2008;.
   PubMed     Related articles   
   
   
   
5. BLANK TO , Bellizzi KM
   A gerontologic perspective on cancer and aging.
   Cancer. 2008;112.
   PubMed     Related articles    Abstract available
   
   
   May 2008
6. AL OTAIBI M , Ross P, Fahmy N, Jeyaganth S, et al
   Role of repeated biopsy of the prostate in predicting disease progression in patients with prostate cancer on active surveillance.
   Cancer. 2008;.
   PubMed     Related articles    Abstract available
   
   
   
7. WEIGHT CJ , Klein EA, Jones JS
   Androgen deprivation falls as orchiectomy rates rise after changes in reimbursement in the U.S. Medicare population.
   Cancer. 2008;112:2195-201.
   PubMed     Related articles    Abstract available
   
   
   April 2008
8. DALL'ERA MA , Konety BR, Cowan JE, Shinohara K, et al
   Active surveillance for the management of prostate cancer in a contemporary cohort.
   Cancer. 2008;.
   PubMed     Related articles    Abstract available
   
   
   
9. BEER TM , Lalani AS, Lee S, Mori M, et al
   C-reactive protein as a prognostic marker for men with androgen-independent prostate cancer: results from the ASCENT trial.
   Cancer. 2008;.
   PubMed     Related articles    Abstract available
   
   
   
10. SCHWARTZ MJ , Hwang DH, Hung AJ, Han J, et al
    Negative influence of changing biopsy practice patterns on the predictive value of prostate-specific antigen for cancer detection on prostate biopsy.
    Cancer. 2008;112:1718-25.
    PubMed     Related articles    Abstract available
    
    
    
11. GLODE LM
    Metabolic syndrome and prostate cancer.
    Cancer. 2008;.
    PubMed     Related articles   
    
    
    
12. CHODAK GW
    Is the increase in orchiectomy for prostate cancer patients appropriate?
    Cancer. 2008;.
    PubMed     Related articles   
    
    
    March 2008
13. SARTOR AO , Tangen CM, Hussain MH, Eisenberger MA, et al
    Antiandrogen withdrawal in castrate-refractory prostate cancer: a Southwest Oncology Group trial (SWOG 9426).
    Cancer. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
14. SMITH MR , Lee H, McGovern F, Fallon MA, et al
    Metabolic changes during gonadotropin-releasing hormone agonist therapy for prostate cancer: differences from the classic metabolic syndrome.
    Cancer. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
15. SUARDI N , Porter CR, Reuther AM, Walz J, et al
    A nomogram predicting long-term biochemical recurrence after radical prostatectomy.
    Cancer. 2008;112:1254-63.
    PubMed     Related articles    Abstract available
    
    
    
16. SONPAVDE G , Garzotto M, Chi KN
    Reply to neoadjuvant therapy followed by prostatectomy for clinically localized prostate cancer.
    Cancer. 2008;.
    PubMed     Related articles   
    
    
    
17. PALMA D , Tyldesley S, Pickles T
    Pretreatment prostate-specific antigen velocity is associated with development of distant metastases and prostate cancer mortality in men treated with radiotherapy and androgen-deprivation therapy.
    Cancer. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
18. KOONTZ BF , Moul J
    Neoadjuvant therapy followed by prostatectomy for clinically localized prostate cancer.
    Cancer. 2008;.
    PubMed     Related articles   
    
    
    
19. D'AMICO AV , Chen MH
    Reply to Duration of Testosterone Suppression and the Risk of Death from Prostate Cancer in Men Treated Using Radiation and 6 Months of Hormone Therapy.
    Cancer. 2008;.
    PubMed     Related articles   
    
    
    
20. PALMA D , Pickles T
    Duration of testosterone suppression and the risk of death from prostate cancer in men treated with radiation and 6 months of hormone therapy.
    Cancer. 2008;.
    PubMed     Related articles   
    
    
    
21. HARNDEN P , Naylor B, Shelley MD, Clements H, et al
    The clinical management of patients with a small volume of prostatic cancer on biopsy: what are the risks of progression? A systematic review and meta-analysis.
    Cancer. 2008;112:971-81.
    PubMed     Related articles    Abstract available
    
    
    
22. WEI JT
    Moving beyond the "1 size fits all" paradigm.
    Cancer. 2008;112:968-70.
    PubMed     Related articles   
    
    
    February 2008
23. DALL'ERA MA , Cooperberg MR, Chan JM, Davies BJ, et al
    Active surveillance for early-stage prostate cancer: review of the current literature.
    Cancer. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
24. ROSS RW , Xie W, Regan MM, Pomerantz M, et al
    Efficacy of androgen deprivation therapy (ADT) in patients with advanced prostate cancer: association between Gleason score, prostate-specific antigen level, and prior ADT exposure with duration of ADT effect.
    Cancer. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
25. ALIBHAI SM , Leach M, Tomlinson GA, Krahn MD, et al
    Is there an optimal comorbidity index for prostate cancer?
    Cancer. 2008;112:1043-1050.
    PubMed     Related articles    Abstract available
    
    
    
26. UZZO RG , Haas NB, Crispen PL, Kolenko VM, et al
    Mechanisms of apoptosis resistance and treatment strategies to overcome them in hormone-refractory prostate cancer.
    Cancer. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
27. VAN DER KNAAP R , Siemes C, Coebergh JW, van Duijn CM, et al
    Renin-angiotensin system inhibitors, angiotensin I-converting enzyme gene insertion/deletion polymorphism, and cancer: the Rotterdam Study.
    Cancer. 2008;112:748-57.
    PubMed     Related articles    Abstract available
    
    
    
28. SANDBLOM G , Ladjevardi S, Garmo H, Varenhorst E, et al
    The impact of prostate-specific antigen level at diagnosis on the relative survival of 28,531 men with localized carcinoma of the prostate.
    Cancer. 2008;112:813-9.
    PubMed     Related articles    Abstract available
    
    
    January 2008
29. SCHLEGEL PN
    "Limited" prostate cancer on biopsy: a note of caution.
    Cancer. 2008;.
    PubMed     Related articles   
    
    
    
30. SVATEK RS , Lee JJ, Roehrborn CG, Lippman SM, et al
    Cost-effectiveness of prostate cancer chemoprevention: a quality of life-years analysis.
    Cancer. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
31. JORGENSEN KT , Pedersen BV, Johansen C, Frisch M, et al
    Fatherhood status and prostate cancer risk.
    Cancer. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
32. WINGO PA , Tucker TC, Jamison PM, Martin H, et al
    Cancer in Appalachia, 2001-2003.
    Cancer. 2008;112:181-92.
    PubMed     Related articles    Abstract available
    
    
    December 2007
33. HOFFMAN KE , Hong TS, Zietman AL, Russell AH, et al
    External beam radiation treatment for rectal cancer is associated with a decrease in subsequent prostate cancer diagnosis.
    Cancer. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
34. ROSS RW , Beer TM, Jacobus S, Bubley GJ, et al
    A phase 2 study of carboplatin plus docetaxel in men with metastatic hormone-refractory prostate cancer who are refractory to docetaxel.
    Cancer. 2007;.
    PubMed     Related articles    Abstract available
    
    
    November 2007
35. AGARWAL PK , Sadetsky N, Konety BR, Resnick MI, et al
    Treatment failure after primary and salvage therapy for prostate cancer: likelihood, patterns of care, and outcomes.
    Cancer. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
36. PISTERS LL
    Treatment failure after primary and salvage therapy for prostate cancer.
    Cancer. 2007;.
    PubMed     Related articles   
    
    
    
37. CHEN RC , Clark JA, Manola J, Talcott JA, et al
    Treatment 'mismatch' in early prostate cancer : do treatment choices take patient quality of life into account?
    Cancer. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
38. HAMILTON RJ , Aronson WJ, Presti JC Jr, Terris MK, et al
    Race, biochemical disease recurrence, and prostate-specific antigen doubling time after radical prostatectomy: results from the SEARCH database.
    Cancer. 2007;110:2202-9.
    PubMed     Related articles    Abstract available
    
    
    
39. POWELL I
    Race, biochemical disease recurrence, and prostate-specific antigen doubling time in the SEARCH database.
    Cancer. 2007;110:2153-4.
    PubMed     Related articles   
    
    
    
40. KATTAN MW , Cuzick J, Fisher G, Berney DM, et al
    Nomogram incorporating PSA level to predict cancer-specific survival for men with clinically localized prostate cancer managed without curative intent.
    Cancer. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
41. ALBERTSEN P
    Predicting survival for men with clinically localized prostate cancer: what do we need in contemporary practice?
    Cancer. 2007;.
    PubMed     Related articles   
    
    
    
42. NORTHOUSE LL , Mood DW, Schafenacker A, Montie JE, et al
    Randomized clinical trial of a family intervention for prostate cancer patients and their spouses.
    Cancer. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
43. EFSTATHIOU JA , Bae K, Shipley WU, Hanks GE, et al
    Obesity and mortality in men with locally advanced prostate cancer: analysis of RTOG 85-31.
    Cancer. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
44. BADANI KK , Kaul S, Menon M
    Evolution of robotic radical prostatectomy: assessment after 2766 procedures.
    Cancer. 2007;110:1951-8.
    PubMed     Related articles    Abstract available
    
    
    
45. BEER TM , Ryan CW
    The hazards of intermediate endpoints.
    Cancer. 2007;110:1877-9.
    PubMed     Related articles   
    
    
    
46. CHENG L , Davidson DD, Lin H, Koch MO, et al
    Percentage of Gleason pattern 4 and 5 predicts survival after radical prostatectomy.
    Cancer. 2007;110:1967-72.
    PubMed     Related articles    Abstract available
    
    
    October 2007
47. ABRAMOWITZ MC , Li T, Buyyounouski MK, Ross E, et al
    The Phoenix definition of biochemical failure predicts for overall survival in patients with prostate cancer.
    Cancer. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
48. BEER TM , Ryan CW, Venner PM, Petrylak DP, et al
    Intermittent chemotherapy in patients with metastatic androgen-independent prostate cancer: results from ASCENT, a double-blinded, randomized comparison of high-dose calcitriol plus docetaxel with placebo plus docetaxel.
    Cancer. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
49. BYLOW K , Mohile SG, Stadler WM, Dale W, et al
    Does androgen-deprivation therapy accelerate the development of frailty in older men with prostate cancer?: a conceptual review.
    Cancer. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
50. XIE W , Nakabayashi M, Regan MM, Oh WK, et al
    Higher prostate-specific antigen levels predict improved survival in patients with hormone-refractory prostate cancer who have skeletal metastases and normal serum alkaline phosphatase.
    Cancer. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
51. SONPAVDE G , Chi KN, Powles T, Sweeney CJ, et al
    Neoadjuvant therapy followed by prostatectomy for clinically localized prostate cancer.
    Cancer. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
52. SPIESS PE , Pettaway CA, Vakar-Lopez F, Kassouf W, et al
    Treatment outcomes of small cell carcinoma of the prostate: a single-center study.
    Cancer. 2007;110:1729-37.
    PubMed     Related articles    Abstract available
    
    
    
53. NAKANISHI H , Wang X, Ochiai A, Trpkov K, et al
    A nomogram for predicting low-volume/low-grade prostate cancer: a tool in selecting patients for active surveillance.
    Cancer. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
54. NGUYEN PL , D'Amico AV, Lee AK, Suh WW, et al
    Patient selection, cancer control, and complications after salvage local therapy for postradiation prostate-specific antigen failure: a systematic review of the literature.
    Cancer. 2007;110:1417-28.
    PubMed     Related articles    Abstract available
    
    
    September 2007
55. SOMMERS BD , Beard CJ, D'Amico AV, Dahl D, et al
    Decision analysis using individual patient preferences to determine optimal treatment for localized prostate cancer.
    Cancer. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
56. ROEMELING S , Roobol MJ, Kattan MW, van der Kwast TH, et al
    Nomogram use for the prediction of indolent prostate cancer: impact on screen-detected populations.
    Cancer. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
57. FLESHNER N , Zlotta AR
    Prostate cancer prevention: past, present, and future.
    Cancer. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
58. CARDUCCI MA , Saad F, Abrahamsson PA, Dearnaley DP, et al
    A phase 3 randomized controlled trial of the efficacy and safety of atrasentan in men with metastatic hormone-refractory prostate cancer.
    Cancer. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
59. PUNGLIA RS , Cullen J, McLeod DG, Chen Y, et al
    Prostate-specific antigen velocity and the detection of gleason score 7 to 10 prostate cancer.
    Cancer. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
60. D'AMICO AV , Renshaw AA, Loffredo B, Chen MH, et al
    Duration of testosterone suppression and the risk of death from prostate cancer in men treated using radiation and 6 months of hormone therapy.
    Cancer. 2007;.
    PubMed     Related articles    Abstract available
    
    
    August 2007
61. ASHLEY RA , Inman BA, Routh JC, Krambeck AE, et al
    Preventing pain during office biopsy of the prostate: a single center, prospective, double-blind, 3-arm, parallel group, randomized clinical trial.
    Cancer. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
62. NGUYEN PL , Chen MH, D'Amico AV, Tempany CM, et al
    Magnetic resonance image-guided salvage brachytherapy after radiation in select men who initially presented with favorable-risk prostate cancer : a prospective phase 2 study.
    Cancer. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
63. ROBBINS AS , Koppie TM, Gomez SL, Parikh-Patel A, et al
    Differences in prognostic factors and survival among white and Asian men with prostate cancer, California, 1995-2004.
    Cancer. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
64. ALLEN GW , Howard AR, Jarrard DF, Ritter MA, et al
    Management of prostate cancer recurrences after radiation therapy-brachytherapy as a salvage option.
    Cancer. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
65. MAGI-GALLUZZI C , Zhou M, Reuther AM, Dreicer R, et al
    Neoadjuvant docetaxel treatment for locally advanced prostate cancer: a clinicopathologic study.
    Cancer. 2007;.
    PubMed     Related articles    Abstract available
    
    
    July 2007
66. HALABI S , Ou SS, Vogelzang NJ, Small EJ, et al
    Inverse correlation between body mass index and clinical outcomes in men with advanced castration-recurrent prostate cancer.
    Cancer. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
67. SAIGAL CS , Gore JL, Krupski TL, Hanley J, et al
    Androgen deprivation therapy increases cardiovascular morbidity in men with prostate cancer.
    Cancer. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
68. MONTGOMERY RB , Nelson PS, Lin D, Ryan CW, et al
    Diethylstilbestrol and docetaxel: a phase II study of tubulin active agents in patients with metastatic, androgen-independent prostate cancer.
    Cancer. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
69. STROUP SP , Cullen J, Auge BK, L'esperance JO, et al
    Effect of obesity on prostate-specific antigen recurrence after radiation therapy for localized prostate cancer as measured by the 2006 Radiation Therapy Oncology Group-American Society for Therapeutic Radiation and Oncology (RTOG-ASTRO) Phoenix consensu
    Cancer. 2007;.
    PubMed     Related articles    Abstract available
    
    
    June 2007
70. MOURAVIEV V , Mayes JM, Sun L, Madden JF, et al
    Prostate cancer laterality as a rationale of focal ablative therapy for the treatment of clinically localized prostate cancer.
    Cancer. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
71. ROSENBERG JE , Weinberg VK, Kelly WK, Michaelson D, et al
    Activity of second-line chemotherapy in docetaxel-refractory hormone-refractory prostate cancer patients : randomized phase 2 study of ixabepilone or mitoxantrone and prednisone.
    Cancer. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
72. DATTOLI M , Wallner K, True L, Cash J, et al
    Long-term outcomes after treatment with brachytherapy and supplemental conformal radiation for prostate cancer patients having intermediate and high-risk features.
    Cancer. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
73. KULKARNI GS , Lockwood G, Evans A, Toi A, et al
    Clinical predictors of Gleason score upgrading: implications for patients considering watchful waiting, active surveillance, or brachytherapy.
    Cancer. 2007;109:2432-8.
    PubMed     Related articles    Abstract available
    
    
    
74. MILLER DC , Spencer BA, Shah RB, Ritchey J, et al
    The quality of surgical pathology care for men undergoing radical prostatectomy in the U.S.
    Cancer. 2007;109:2445-53.
    PubMed     Related articles    Abstract available
    
    
    
75. ROCCO B , Scardino E, de Cobelli O
    Locally advanced prostate cancer: Biochemical results from a prospective phase II study of intermittent androgen suppression for men with evidence of prostate-specific antigen recurrence after radiotherapy.
    Cancer. 2007;.
    PubMed     Related articles   
    
    
    
76. MERRICK GS , Galbreath RW, Butler WM, Waller KE, et al
    Primary Gleason pattern does not impact survival after permanent interstitial brachytherapy for Gleason score 7 prostate cancer.
    Cancer. 2007;.
    PubMed     Related articles    Abstract available
    
    
    May 2007
77. D'AMICO AV , Chen MH, Catalona WJ, Sun L, et al
    Prostate cancer-specific mortality after radical prostatectomy or external beam radiation therapy in men with 1 or more high-risk factors.
    Cancer. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
78. MORGAN PB , Hanlon AL, Horwitz EM, Buyyounouski MK, et al
    Timing of biochemical failure and distant metastatic disease for low-, intermediate-, and high-risk prostate cancer after radiotherapy.
    Cancer. 2007;.
    PubMed     Related articles    Abstract available   Free Full Text
    
    
    
79. RYAN CJ , Elkin EP, Cowan J, Carroll PR, et al
    Initial treatment patterns and outcome of contemporary prostate cancer patients with bone metastases at initial presentation: data from CaPSURE.
    Cancer. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
80. EADE TN , Al-Saleem T, Horwitz EM, Buyyounouski MK, et al
    Role of radiotherapy in ductal (endometrioid) carcinoma of the prostate.
    Cancer. 2007;109:2011-5.
    PubMed     Related articles    Abstract available
    
    
    
81. D'AMICO AV , Denham JW, Bolla M, Collette L, et al
    Short- vs long-term androgen suppression plus external beam radiation therapy and survival in men of advanced age with node-negative high-risk adenocarcinoma of the prostate.
    Cancer. 2007;109:2004-10.
    PubMed     Related articles    Abstract available
    
    
    
82. MARIOTTO AB , Etzioni R, Krapcho M, Feuer EJ, et al
    Reconstructing PSA testing patterns between black and white men in the US from Medicare claims and the National Health Interview Survey.
    Cancer. 2007;109:1877-86.
    PubMed     Related articles    Abstract available
    
    
    April 2007
83. LITWIN MS , Gore JL, Kwan L, Brandeis JM, et al
    Quality of life after surgery, external beam irradiation, or brachytherapy for early-stage prostate cancer.
    Cancer. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
84. JAYADEVAPPA R , Johnson JC, Chhatre S, Wein AJ, et al
    Ethnic variation in return to baseline values of patient-reported outcomes in older prostate cancer patients.
    Cancer. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
85. LEE WR , Bae K, Lawton C, Gillin M, et al
    Late toxicity and biochemical recurrence after external-beam radiotherapy combined with permanent-source prostate brachytherapy: analysis of Radiation Therapy Oncology Group study 0019.
    Cancer. 2007;109:1506-12.
    PubMed     Related articles    Abstract available
    
    
    
86. FREEDLAND SJ , Partin AW, Humphreys EB, Mangold LA, et al
    Radical prostatectomy for clinical stage T3a disease.
    Cancer. 2007;109:1273-8.
    PubMed     Related articles    Abstract available
    
    
    March 2007
87. KNIGHT SJ , Latini DM, Hart SL, Sadetsky N, et al
    Education predicts quality of life among men with prostate cancer cared for in the department of Veterans affairs: a longitudinal quality of life analysis from CaPSURE.
    Cancer. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
88. LITWIN MS , Greenfield S, Elkin EP, Lubeck DP, et al
    Assessment of prognosis with the total illness burden index for prostate cancer: aiding clinicians in treatment choice.
    Cancer. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
89. TALCOTT JA , Spain P, Clark JA, Carpenter WR, et al
    Hidden barriers between knowledge and behavior: the North Carolina prostate cancer screening and treatment experience.
    Cancer. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
90. EFSTATHIOU JA , Chen MH, Renshaw AA, Loffredo MJ, et al
    Influence of body mass index on prostate-specific antigen failure after androgen suppression and radiation therapy for localized prostate cancer.
    Cancer. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
91. PINSKY PF , Andriole G, Crawford ED, Chia D, et al
    Prostate-specific antigen velocity and prostate cancer gleason grade and stage.
    Cancer. 2007;.
    PubMed     Related articles    Abstract available
    
    
    February 2007
92. SHIGEMURA K , Arbiser JL, Sun SY, Zayzafoon M, et al
    Honokiol, a natural plant product, inhibits the bone metastatic growth of human prostate cancer cells.
    Cancer. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
93. D'AMICO AV , McLeod DG, Carroll PR, Cullen J, et al
    Time to an undetectable prostate-specific antigen (PSA) after androgen suppression therapy for postoperative or postradiation PSA recurrence and prostate cancer-specific mortality.
    Cancer. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
94. OH WK , Proctor K, Nakabayashi M, Evan C, et al
    The risk of renal impairment in hormone-refractory prostate cancer patients with bone metastases treated with zoledronic acid.
    Cancer. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
95. GONG Z , Agalliu I, Lin DW, Stanford JL, et al
    Obesity is associated with increased risks of prostate cancer metastasis and death after initial cancer diagnosis in middle-aged men.
    Cancer. 2007;.
    PubMed     Related articles    Abstract available
    
    
    January 2007
96. BEEBE-DIMMER JL , Dunn RL, Sarma AV, Montie JE, et al
    Features of the metabolic syndrome and prostate cancer in African-American men.
    Cancer. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
97. BRUCHOVSKY N , Klotz L, Crook J, Goldenberg SL, et al
    Locally advanced prostate cancer-biochemical results from a prospective phase II study of intermittent androgen suppression for men with evidence of prostate-specific antigen recurrence after radiotherapy.
    Cancer. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
98. MOHILE SG , Bylow K, Dale W, Dignam J, et al
    A pilot study of the vulnerable elders survey-13 compared with the comprehensive geriatric assessment for identifying disability in older patients with prostate cancer who receive androgen ablation.
    Cancer. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
99. WRIGHT ME , Chang SC, Schatzkin A, Albanes D, et al
    Prospective study of adiposity and weight change in relation to prostate cancer incidence and mortality.
    Cancer. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
100. KENDAL W , Eapen L, Nicholas G
     Second primary cancers after prostatic irradiation: ensuring an appropriate analysis.
     Cancer. 2007;109:164.
     PubMed     Related articles   
     
     
     
101. HARNDEN P , Shelley MD, Clements H, Coles B, et al
     The prognostic significance of perineural invasion in prostatic cancer biopsies: a systematic review.
     Cancer. 2007;109:13-24.
     PubMed     Related articles    Abstract available
     
     
     December 2006
102. OH WK , Tay MH, Huang J
     Is there a role for platinum chemotherapy in the treatment of patients with hormone-refractory prostate cancer?
     Cancer. 2006;.
     PubMed     Related articles    Abstract available
     
     
     
103. WILSON LS , Tesoro R, Elkin EP, Sadetsky N, et al
     Cumulative cost pattern comparison of prostate cancer treatments.
     Cancer. 2006;.
     PubMed     Related articles    Abstract available
     
     
     
104. SAROSDY MF
     Testosterone replacement for hypogonadism after treatment of early prostate cancer with brachytherapy.
     Cancer. 2006;.
     PubMed     Related articles    Abstract available
     
     
     
105. CAMPBELL LC , Keefe FJ, Scipio C, McKee DC, et al
     Facilitating research participation and improving quality of life for African American prostate cancer survivors and their intimate partners : a pilot study of telephone-based coping skills training.
     Cancer. 2006;.
     PubMed     Related articles    Abstract available
     
     
     
106. ZHANG H , Wu Y, Malewicz B, Lu J, et al
     Augmented suppression of androgen receptor signaling by a combination of alpha-tocopheryl succinate and methylseleninic acid.
     Cancer. 2006;107:2942-8.
     PubMed     Related articles    Abstract available
     
     
     
107. LEIBOVICI D , Spiess PE, Agarwal PK, Tu SM, et al
     Prostate cancer progression in the presence of undetectable or low serum prostate-specific antigen level.
     Cancer. 2006;.
     PubMed     Related articles    Abstract available
     
     
     
108. ROACH M 3RD , Weinberg V, Sandler H, Thompson I, et al
     Staging for prostate cancer: time to incorporate pretreatment prostate-specific antigen and Gleason score?
     Cancer. 2006;.
     PubMed     Related articles    Abstract available
     
     
     
109. SARTOR O , Reid RH, Bushnell DL, Quick DP, et al
     Safety and efficacy of repeat administration of samarium Sm-153 lexidronam to patients with metastatic bone pain.
     Cancer. 2006;.
     PubMed     Related articles    Abstract available
     
     
     November 2006
110. ALCAANTARA P , Hanlon A, Buyyounouski MK, Horwitz EM, et al
     Prostate-specific antigen nadir within 12 months of prostate cancer radiotherapy predicts metastasis and death.
     Cancer. 2006;.
     PubMed     Related articles    Abstract available
     
     
     
111. ROEMELING S , Kranse R, Vis AN, Gosselaar C, et al
     Metastatic disease of screen-detected prostate cancer : characteristics at diagnosis.
     Cancer. 2006;.
     PubMed     Related articles    Abstract available
     
     
     
112. COOPERBERG MR , Freedland SJ, Pasta DJ, Elkin EP, et al
     Multiinstitutional validation of the UCSF cancer of the prostate risk assessment for prediction of recurrence after radical prostatectomy.
     Cancer. 2006;107:2384-91.
     PubMed     Related articles    Abstract available
     
     
     
113. OSMAN I , Dai J, Mikhail M, Navarro D, et al
     Loss of neutral endopeptidase and activation of protein kinase B (Akt) is associated with prostate cancer progression.
     Cancer. 2006;.
     PubMed     Related articles    Abstract available
     
     
     October 2006
114. KORNBLITH AB , Dowell JM, Herndon JE 2nd, Engelman BJ, et al
     Telephone monitoring of distress in patients aged 65 years or older with advanced stage cancer: a cancer and leukemia group B study.
     Cancer. 2006;.
     PubMed     Related articles    Abstract available
     
     
     
115. TWARD JD , Lee CM, Pappas LM, Szabo A, et al
     Survival of men with clinically localized prostate cancer treated with prostatectomy, brachytherapy, or no definitive treatment: impact of age at diagnosis.
     Cancer. 2006;.
     PubMed     Related articles    Abstract available
     
     
     
116. TSAI HK , Chen MH, McLeod DG, Carroll PR, et al
     Cancer-specific mortality after radiation therapy with short-course hormonal therapy or radical prostatectomy in men with localized, intermediate-risk to high-risk prostate cancer.
     Cancer. 2006;.
     PubMed     Related articles    Abstract available
     
     
     September 2006
117. MOLS F , van de Poll-Franse LV, Vingerhoets AJ, Hendrikx A, et al
     Long-term quality of life among Dutch prostate cancer survivors: results of a population-based study.
     Cancer. 2006;.
     PubMed     Related articles    Abstract available
     
     
     
118. PETIT JH , Chen MH, Loffredo M, Sussman B, et al
     Prostate-specific antigen recurrence and mortality after conventional dose radiation therapy in select men with low-risk prostate cancer.
     Cancer. 2006;.
     PubMed     Related articles    Abstract available
     
     
     August 2006
119. SIDDIQUI SA , Inman BA, Sengupta S, Slezak JM, et al
     Obesity and survival after radical prostatectomy: A 10-year prospective cohort study.
     Cancer. 2006;107:521-9.
     PubMed     Related articles    Abstract available
     
     

Thank you for your interest in scientific medicine.

Amedeo is a Bernd Sebastian Kamps website.    Design: